Graves’ Disease Plasma

In Stock Samples

Lot # Condition Volume Race/Ethnicity Age Gender Country of Collection Medications Vials Price Action
69460 Graves' Disease 1.0 ML Asian/Pacific Islander 26 Female
methamisol 2.25 mg 5 days a week
16 $495.00
70526 Graves' Disease 1.0 ML Native American 63 Male 16 $495.00
73325 Graves' Disease 1.0 ML Hispanic/Latino 38 Female United States (US)
levothyroxine 125mcg QD
15 $495.00
71781 Graves' Disease 1.0 ML Asian/Pacific Islander 38 Male United States (US)
Methimazole 5mg QD; QVAR 80mcg/2xday; Propranolol 10mg QD
9 $495.00
69442 Graves' Disease 1.0 ML Caucasian 44 Female United States (US)
Methimazole 10mg daily, other supplements Methimazole, 5mg, QD Iron, 65mg QD Vitamin D3, 5000 U, QD Pro-Air, PID Vitamin B-12, QD Albuterol Inh PRN busparone 10mg QD
14 $495.00
69353 Graves' Disease 1.0 ML African American 60 Female United States (US)
Vitamins, C, E, D, biotin, selenium, velafaxine 150mg and 75mg, Meloxicam, methamazol, metoprolol, atorvastatin, buspar Adorvastin Venlofaxin Metropolol
16 $495.00
69291 Graves' Disease 1.0 ML Asian/Pacific Islander 66 Male United States (US)
No medications
8 $495.00
69382 Graves' Disease 1.0 ML Caucasian 63 Female United States (US)
Levothyroxine, liothyronine. Temazapam Levothyroxine 88 mcg QD Liothyronine 5 mcg QD Hizentra 12gm/60 ml Infusion QD
16 $495.00
68848 Graves' Disease 1.0 ML Native American 63 Male United States (US) 14 $495.00

Graves’ Disease Plasma | High-Quality Human Plasma from Graves’ Disease Donors

Graves’ Disease Plasma is collected from donors clinically diagnosed with Graves’ Disease and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in Graves’ Disease pathophysiology.

Product Features

  • Research Use Only (RUO)
  • Plasma collected from clinically confirmed Graves’ Disease donors
  • Processed within one day of collection
  • IRB-approved protocols and informed consent
  • Custom aliquot volumes available upon request

De-identified Donor Data

  • Verified Graves’ Disease diagnosis
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Donor-reported medications, allergies, and comorbidities
  • Additional Graves’ Disease-specific metadata available

Applications

  • Biomarker discovery and validation
  • Cytokine and inflammation profiling
  • Metabolomics and proteomics studies
  • Therapeutic response research

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Graves’ Disease plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.

Protocols & Documentation

  • Plasma Isolation

    Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Plasma

Frequently Asked Questions

Showing 25–31 of 31 results

Do plasma samples come with clinical information (autoantibody status, HbA1c values, IHC results, stage information, genetic mutation data)?

1 Answer

YES – Comprehensive medical records are available and may contain information regarding autoantibody status.

YES – Sanguine offers both inventory for select conditions, as well as, prospective collection. For inventory visit https://sanguinebio.com/products/plasma/?pro_inventory=inventory.

We never thaw our plasma samples before shipping.

Our standard aliquot size for plasma is 1 mL but we have bulk plasma (50 to 150 mL) available for select conditions. https://sanguinebio.com/product/human-bulk-plasma/

YES – Sanguine bio provides “age-matched healthy controls” and longitudinal studies capabilities.

YES – custom age specifications available – The “Specify I/E Criteria” service allows you to define specific age ranges for donor selection.

Age ranges available – Donor metadata includes age specifications, and you can specify inclusion/exclusion criteria. For pediatric samples specifically, contact learnmore@sanguinebio.com.

1 2 3
×

Ask a Question

Need a custom Plasma cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information